Elephas logo

Elephas Funding & Investors

Disruption in healthcare is being accelerated by the need for improved diagnostics, novel pharmaceutical therapies, and the shift to patient-centric solutions. With the mission to tackle the massive oncology dilemma, Elephas is leading the way to change how clinicians treat cancer patients. By harnessing the latest advances in cancer biology, multimodal microscopy, and artificial intelligence, the Elephas platform has the ability to empower clinical decision making and accelerate drug development. We plan to use the power of our platform to deliver a global solution that can revolutionize cancer treatment for every individual.

elephas.com

Total Amount Raised: $178,500,000

Elephas Funding Rounds

  • Series C

    $55,000,000

    Series C Investors

    State of Wisconsin Investment Board
    ArchVentures
    Northpond Ventures
    Sands Capital Ventures
    Moore Strategic Ventures
    Tao Investments
    WARF Ventures
  • Series C

    $55,000,000

    Series C Investors

    State of Wisconsin Investment Board
    Venture Investors
    Moore Strategic Ventures
    Sands Capital Ventures
    Northpond Ventures
    Arch Venture Partners
    WARF Ventures
    Tao Capital Partners
  • Series B

    $41,500,000

    Series B Investors

    Arch Venture Partners
    Tao Capital Partners
    Moore Strategic Ventures
    WARF Ventures
    Sands Capital Ventures
    Northpond Ventures
  • Series A

    $20,000,000

    Series A Investors

    Northpond Ventures
    WARF Ventures
    Sands Capital Ventures
  • Seed

    $1,000,000

  • Seed

    $6,000,000

Funding info provided by Diffbot.